| 000 | 01757 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250517081301.0 | ||
| 264 | 0 | _c20161213 | |
| 008 | 201612s 0 0 eng d | ||
| 022 | _a1942-0994 | ||
| 024 | 7 |
_a10.1155/2016/2189582 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMartins, La Salete | |
| 245 | 0 | 0 |
_aAdvanced Glycation End Products Evolution after Pancreas-Kidney Transplantation: Plasmatic and Cutaneous Assessments. _h[electronic resource] |
| 260 |
_bOxidative medicine and cellular longevity _c2016 |
||
| 300 |
_a2189582 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aBiopsy |
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 1 _xcomplications |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlycation End Products, Advanced _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunohistochemistry |
| 650 | 0 | 4 | _aImmunosuppression Therapy |
| 650 | 0 | 4 |
_aKidney Transplantation _xadverse effects |
| 650 | 0 | 4 |
_aLysine _xanalogs & derivatives |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aOxygen _xchemistry |
| 650 | 0 | 4 |
_aPancreas Transplantation _xadverse effects |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aProteins _xchemistry |
| 650 | 0 | 4 |
_aSkin _xmetabolism |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aOliveira, José C | |
| 700 | 1 | _aVizcaíno, José Ramón | |
| 700 | 1 | _aFonseca, Isabel | |
| 700 | 1 | _aGouveia, Carlos | |
| 700 | 1 | _aSilva, Donzília | |
| 700 | 1 | _aHenriques, António C | |
| 700 | 1 | _aNoronha, Irene L | |
| 700 | 1 | _aRodrigues, Anabela | |
| 773 | 0 |
_tOxidative medicine and cellular longevity _gvol. 2016 _gp. 2189582 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1155/2016/2189582 _zAvailable from publisher's website |
| 999 |
_c25736797 _d25736797 |
||